1. Home
  2. WWW vs BLFS Comparison

WWW vs BLFS Comparison

Compare WWW & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wolverine World Wide Inc.

WWW

Wolverine World Wide Inc.

HOLD

Current Price

$17.97

Market Cap

2.2B

ML Signal

HOLD

Logo BioLife Solutions Inc.

BLFS

BioLife Solutions Inc.

HOLD

Current Price

$24.20

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WWW
BLFS
Founded
1883
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.2B
IPO Year
N/A
1989

Fundamental Metrics

Financial Performance
Metric
WWW
BLFS
Price
$17.97
$24.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$25.43
$31.50
AVG Volume (30 Days)
1.5M
319.6K
Earning Date
02-18-2026
11-06-2025
Dividend Yield
2.20%
N/A
EPS Growth
N/A
N/A
EPS
1.07
N/A
Revenue
$1,851,500,000.00
$100,144,000.00
Revenue This Year
$7.35
$20.67
Revenue Next Year
$5.41
$14.13
P/E Ratio
$16.98
N/A
Revenue Growth
3.61
87.53
52 Week Low
$9.58
$19.10
52 Week High
$32.80
$29.62

Technical Indicators

Market Signals
Indicator
WWW
BLFS
Relative Strength Index (RSI) 48.59 37.63
Support Level $17.65 $24.95
Resistance Level $18.35 $25.63
Average True Range (ATR) 0.62 0.68
MACD 0.08 -0.02
Stochastic Oscillator 30.06 2.34

Price Performance

Historical Comparison
WWW
BLFS

About WWW Wolverine World Wide Inc.

Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: